Immunome (IMNM) Insider Trading & Ownership → Nvidia’s Quiet $1 Trillion Pivot (From Weiss Ratings) (Ad) Free IMNM Stock Alerts $14.62 +0.40 (+2.81%) (As of 05/28/2024 ET) Add Compare Share Share Insider TradesStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsStock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Immunome (NASDAQ:IMNM) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage8.60%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$1.28 MNumber OfInsiders Selling(Last 12 Months)0 Get IMNM Insider Trade Alerts Want to know when executives and insiders are buying or selling Immunome stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IMNM Insider Buying and Selling by Quarter Ad Resource Stock DigestDigitizing the $11T commodities sector with one tiny stockOne tiny company — trading completely undiscovered around 15-cents per share — has successfully partnered with some of the largest players in the industry to bring a first-of-its-kind digital solution to the global commodities supply chain sector. It’s an opportunity that likely won’t stay at these levels for long Immunome Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails5/21/2024Jean Jacques BienaimeDirectorBuy2,000$13.57$27,140.00 10/2/2023Bruce TurnerInsiderBuy42,300$5.91$249,993.00 10/2/2023Clay B SiegallCEOBuy169,204$5.91$999,995.64 (Data available from 1/1/2013 forward) IMNM Insider Trading Activity - Frequently Asked Questions Who is on Immunome's Insider Roster? The list of insiders at Immunome includes Bruce Turner, Clay B Siegall, Jean Jacques Bienaime, and Michael Rapp. Learn more on insiders at IMNM. What percentage of Immunome stock is owned by insiders? 8.60% of Immunome stock is owned by insiders. Learn more on IMNM's insider holdings. Which Immunome insiders have been buying company stock? The following insiders have purchased IMNM shares in the last 24 months: Bruce Turner ($249,993.00), Clay B Siegall ($999,995.64), and Jean Jacques Bienaime ($27,140.00). How much insider buying is happening at Immunome? Insiders have purchased a total of 213,504 IMNM shares in the last 24 months for a total of $1,277,128.64 bought. More Insider Trading Tools from MarketBeat Related Companies: TNGX Insider Trading ZNTL Insider Trading ARCT Insider Trading AUPH Insider Trading LBPH Insider Trading NRIX Insider Trading SPRY Insider Trading CNTA Insider Trading IRON Insider Trading PRAX Insider Trading Insider Tracking Tools: CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country: U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles: 3 Stocks Insiders are Buying That Should be on Your RadarInsider Trading is Good News for These Stocks4 Small-Cap Energy Stocks Insiders are Buying 3 Penny Stocks That Insiders Are BuyingThe 3 Hottest Insiders Buys This Month This page (NASDAQ:IMNM) was last updated on 5/28/2024 by MarketBeat.com Staff From Our PartnersWARNING about the death of the U.S. dollar…Colonial MetalsDigitizing the $11T commodities sector with one tiny stockResource Stock DigestNvidia is Pivoting to Solve Big Tech’s $1 Trillion ProblemWeiss RatingsHe Is Giving Away BitcoinCrypto Swap ProfitsExposed: 10 CENT Crypto to Explode May 20th?True Market InsidersElon’s New Device is About to Shock the WorldInvestorPlaceMissed NVDA? Buy this AI stock NOWChaikin AnalyticsThe #1 Crypto That You Don’t Own… YetCrypto 101 Media Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Immunome, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
